These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1683964)

  • 1. Prevention and management of ovarian hyperstimulation syndrome.
    Waterstone J; Bennett S; Ribeiro R; Curson R; Parsons J
    Lancet; 1991 Dec; 338(8781):1536-7. PubMed ID: 1683964
    [No Abstract]   [Full Text] [Related]  

  • 2. In reference to follicular aspiration.
    Meldrum D
    J Assist Reprod Genet; 1992 Jun; 9(3):190. PubMed ID: 1525445
    [No Abstract]   [Full Text] [Related]  

  • 3. Repeated aspiration of ovarian follicles and early corpus luteum cysts in an in-vitro fertilization programme reduces the risk of ovarian hyperstimulation syndrome in high responders.
    Amit A; Yaron Y; Yovel I; Peyser MR; David MP; Botchan A; Lessing JB
    Hum Reprod; 1993 Aug; 8(8):1184-6. PubMed ID: 8408514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current management of ovarian hyperstimulation syndrome.
    Shanbhag S; Bhattacharya S
    Hosp Med; 2002 Sep; 63(9):528-32. PubMed ID: 12357854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timed unilateral ovarian follicular aspiration prior to administration of human chorionic gonadotrophin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization: a prospective randomized study.
    Egbase PE; Makhseed M; Al Sharhan M; Grudzinskas JG
    Hum Reprod; 1997 Dec; 12(12):2603-6. PubMed ID: 9455821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical ovarian hyperstimulation syndrome in a coasted in-vitro fertilization patient.
    Tortoriello DV; McGovern PG; Colon JM; Loughlin J; Santoro N
    Hum Reprod; 1998 Nov; 13(11):3005-8. PubMed ID: 9853846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study.
    Egbase PE; Sharhan MA; Grudzinskas JG
    Hum Reprod; 1999 Jun; 14(6):1421-5. PubMed ID: 10357951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early hCG administration as an alternative prevention strategy of ovarian hyperstimulation syndrome during an IVF cycle.
    Son WY; Dahan MH; Monnier P; Holzer H; Nayot D
    Minerva Ginecol; 2017 Apr; 69(2):207-209. PubMed ID: 28150929
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe ovarian hyperstimulation after follicular aspiration.
    van der Merwe JP; Michell WL; Kruger TF
    S Afr Med J; 1988 Apr; 73(7):426-7. PubMed ID: 3128879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four years of experience with ultrasound-guided follicle aspiration.
    Feichtinger W; Putz M; Kemeter P
    Ann N Y Acad Sci; 1988; 541():138-42. PubMed ID: 2973763
    [No Abstract]   [Full Text] [Related]  

  • 11. Less may, indeed, be less: multicollinearity in studies of ovarian reserve.
    Barad DH; Gleicher N
    Fertil Steril; 2009 May; 91(5):e16; author reply e17-8. PubMed ID: 19230879
    [No Abstract]   [Full Text] [Related]  

  • 12. Ovarian hyperstimulation syndrome.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S188-93. PubMed ID: 19007627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autotransfusion of the ascitic fluid in the treatment of severe ovarian hyperstimulation syndrome.
    Aboulghar MA; Mansour RT; Serour GI; Riad R; Ramzi AM
    Fertil Steril; 1992 Nov; 58(5):1056-9. PubMed ID: 1426358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Overstimulation of the ovary: prevention and treatment].
    Antoine JM
    J Gynecol Obstet Biol Reprod (Paris); 2003; 32(3 Pt 2):S41-5. PubMed ID: 12773918
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical applications of anti-Müllerian hormone in evaluating ovarian reserve functions].
    Yu M; Deng CY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):114-9. PubMed ID: 19317075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study to determine whether serum follicle-stimulating hormone can be a marker for ovarian hyperresponse to follicle-maturing drugs for in vitro fertilization.
    Check JH; Pesso R; Peymer M
    Gynecol Obstet Invest; 1997; 43(4):242-4. PubMed ID: 9194622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular aspiration does not protect against the development of ovarian hyperstimulation syndrome.
    Aboulghar MA; Mansour RT; Serour GI; Elattar I; Amin Y
    J Assist Reprod Genet; 1992 Jun; 9(3):238-43. PubMed ID: 1525453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and management of ovarian hyperstimulation syndrome.
    Chen CD; Chen SU; Yang YS
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):817-27. PubMed ID: 22647872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ovarian hyperstimulation syndrome during in vitro fertilization stimulations. Comparison between the experience of the Center for Medically Assisted Procreation of the Saint Antoine maternity department and a review of the literature].
    Guettier X; Larue L; Chamorand E; Barbier D; Jault T; Liou Y; Marpeau L; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(8):887-95. PubMed ID: 1491132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of ovarian hyperstimulation syndrome guidelines. Produced on behalf of the BFS Policy and Practice Committee.
    Tan BK; Mathur R;
    Hum Fertil (Camb); 2013 Sep; 16(3):160-1. PubMed ID: 23705631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.